Vepesid 50 mg – DIN 00616192
Vepesid is Etoposide 50 mg (capsule), sold in Canada. It is used for prostate cancer, urinary bladder neoplasms and brain neoplasms. It is supplied by Cheplapharm Arzneimittel GmbH. We don't have a photo or description of what this pill looks like yet, so check the name and code on the box or bottle, and ask a pharmacist before taking it. Its official Health Canada listing links to the product monograph, which describes the tablets.
Sold in Canada
Etoposide 50 mg
- Brand
- Vepesid
- Strength
- 50 mg
- Used for
- Prostate cancer, urinary bladder neoplasms and brain neoplasms
- Form
- Capsule
- Manufacturer
- Cheplapharm Arzneimittel GmbH
- Drug class
- Topoisomerase inhibitor
- Sold in
- Canada
- DIN
- 00616192
Source: Health Canada's Drug Product Database. Last checked .
Report a mistake
What is Etoposide used for?
Etoposide is used for prostate cancer, urinary bladder neoplasms and brain neoplasms.
- Medicine type
- Topoisomerase inhibitor
Official uses from the US prescribing label
VePesid (etoposide) is indicated in the management of: Small Cell Lung Cancer—Etoposide capsules in combination with other approved chemotherapeutic agents as first line treatment in patients with small cell lung cancer.
From the FDA-approved label on DailyMed (published Oct 05, 2026).
Doctors sometimes prescribe a medicine for other reasons too. If you are not sure what yours is for, ask your pharmacist.
Is this your medicine? Check the box
- The box or bottle shows DIN 00616192.
- It names Vepesid, Etoposide 50 mg.
- A loose pill is a different matter: without a description of its markings, a pharmacist has to confirm what it is.
Sold in Canada as Vepesid by Cheplapharm Arzneimittel GmbH.
In Canada: prescription only.
Ingredients
Active: Etoposide
